The Tablet That Cracked COVID by Dr. Joseph Mercola
There’s a medication that has been found to reduce COVID-19 mortality by 81%.1 The icing on the cake? It’s also safe, inexpensive and widely available, with decades of clinical usage suggesting it has a “high margin of safety.”2 The drug is ivermectin — a broad-spectrum anti-parasitic that also has anti-inflammatory activity.
There’s a good chance, however, that you probably haven’t heard about it. And, if you or a loved one had COVID-19, there’s also a high probability that you didn’t receive this potentially life-saving treatment, even though doctors have been begging health agencies to make it part of official COVID-19 treatment guidelines since nearly the start of the pandemic.
One professor and doctor, Hector Carvallo, who has found his science documenting ivermectin’s effectiveness for COVID-19 “quickly scrubbed from the internet,” wrote to colleagues, “I am afraid we have affected the most sensitive organ on humans: the wallet.”3
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
In June 2021, we’re at the point when the data on ivermectin are really undebatable. It’s a safe, existing option to treat COVID-19, and an alternative to vaccination, but if it were to become mainstream, it would make the COVID-19 vaccine Emergency Use Authorization disappear because, with a readily available treatment, there’s no need for mass, emergency vaccination.
Critical Care Physicians Developed COVID Treatment Early On
Early on in the pandemic, five critical care physicians formed the Front Line COVID-19 Critical Care Working Group (FLCCC), which developed a highly effective COVID-19 treatment protocol known as MATH+.
One of those physicians, Dr. Paul Marik, a critical care doctor at Sentara Norfolk General Hospital in East Virginia, is renowned for his work in creating the “Marik Cocktail,” which significantly reduces death rates from sepsis using inexpensive, safe, generic medications.4
Not content to offer COVID-19 patients “supportive care,” which he describes as “no care at all,” he recruited some of the most knowledgeable pulmonary critical care specialists to solve the COVID-19 treatment puzzle, homing in on stopping the hyper-immune response — including multiorgan inflammation and clotting — which is what typically drives death in fatal COVID-19 cases.
Marik told Mountain Home magazine, “As pulmonary critical care doctors we know how to treat inflammation and clotting, with corticosteroids and anticoagulants. It’s first-grade science.”6 The result was the MATH+ protocol for hospitalized COVID-19 patients mentioned earlier, which gets its name from:
Intravenous Methylprednisolone
High-dose intravenous Ascorbic acid (vitamin C)
Plus optional treatments Thiamine, zinc and vitamin D
Full dose low molecular weight Heparin
The MATH+ protocol led to high survival rates. Out of more than 100 hospitalized COVID-19 patients treated with the MATH+ protocol as of mid-April 2020, only two died. Both were in their 80s and had advanced chronic medical conditions.7
After several tweaks and updates, the prophylaxis and early outpatient treatment protocol is now known as I-MASK+8 while the hospital treatment has been renamed I-MATH+,9 due to the addition of ivermectin.
Ivermectin ‘Miracle Drug’ Silenced
In December 2020, FLCCC called for widespread adoption of ivermectin, both as a prophylactic and for the treatment of all phases of COVID-19.10,11 In one trial, 58 volunteers took 12 milligrams of ivermectin once per month for four months.
Only four (6.96%) came down with mild COVID-19 symptoms during the May through August 2020 trial period. In comparison, 44 of 60 health care workers (73.3%) who had declined the medication were diagnosed with COVID-19.12 Mountain Home reported:13
